2021
DOI: 10.1016/j.ejmg.2021.104168
|View full text |Cite
|
Sign up to set email alerts
|

A rare case of an NLRP12-associated autoinflammatory disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 13 publications
0
8
0
Order By: Relevance
“…We interpreted these data as an additional example of possible low penetrance of NLRP12 variants, as recently discussed. 17 …”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…We interpreted these data as an additional example of possible low penetrance of NLRP12 variants, as recently discussed. 17 …”
Section: Resultsmentioning
confidence: 99%
“…11 To date, few such patients were identified (see ref. 17 for the most recent description) but the association between NLRP12 variants and spontaneous inflammation is not yet firmly established, nor is the molecular role of this inflammasome in the establishment of systemic inflammatory settings. 1 9 In this work, we described a patient with late onset autoinflammatory syndromes which was diagnosed a likely FCAS2 based on the identification, by targeted gene resequencing, of a NLRP12 variant of unknown significance (although several bioinformatics programmes suggest potential damaging consequences of this mutation, see online supplemental table II) which has not been ascribed so far as causal for any disease.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… 1 This gene encodes for NLRP12 protein, a member of the larger family of NOD-like receptor, which acts as a negative regulator of inflammation, suppressing nuclear factor-κB activation and subsequent production of proinflammatory cytokines and chemokines, such as interleukin (IL)-1, IL-6, and IL-8. 1 , 4 , 6 Since the first report of NLRP12 as a causative gene of AIDs, at least 62 cases of FCAS-2 have been discovered worldwide. 6 Our patient carried simultaneously 2 mutations: c.625G>A (p.Ala218Thr) and c.910C>T (p.His304Tyr).…”
Section: Discussionmentioning
confidence: 99%
“… 1 , 4 , 6 Since the first report of NLRP12 as a causative gene of AIDs, at least 62 cases of FCAS-2 have been discovered worldwide. 6 Our patient carried simultaneously 2 mutations: c.625G>A (p.Ala218Thr) and c.910C>T (p.His304Tyr). The age at onset of FCAS-2 is variable, ranging from the first year of life to middle age, with a slight male prevalence.…”
Section: Discussionmentioning
confidence: 99%